Investment Rating - The report maintains a "Buy" rating for Haidilao [7] Core Insights - Haidilao is undergoing a strategic transformation, marking a "second entrepreneurship" phase with a focus on core business stability and breakthrough strategies, led by founder Zhang Yong returning as CEO [2][18] - The "Pomegranate Plan" aims to diversify from a single hotpot model to a multi-brand strategy, with significant growth in subsidiary brand revenues [3][45] - The main brand is showing signs of recovery, with improved customer spending and operational metrics validating demand resilience [4][66] - A high dividend policy is in place, providing a safety net for investors, with a dividend payout ratio increasing from 40% in 2022 to 90% in 2023 [4][67] Summary by Sections 1. Strategic Transformation - In early 2026, Haidilao is at a strategic turning point with a focus on upgrading management and operations, shifting from cost-cutting to maintaining core business and focusing on breakthroughs [2][18] - The management structure has been revamped, with experienced female executives joining the board to enhance operational efficiency [19][31] 2. Pomegranate Plan - The "Pomegranate Plan" is designed to break through the ceiling of the hotpot category and incentivize talent, with 14 brands and 126 stores launched by mid-2025, achieving a revenue growth of 227% year-on-year for subsidiary brands [3][45] - Key focus areas include seafood restaurants, sushi, and takeout services, with a strong emphasis on fresh ingredients and customer experience [3][49][52] 3. Main Brand Performance - The main brand has stabilized, with an average customer spending of 97.9 yuan in the first half of 2025, showing a recovery trend [4][59] - The restaurant's turnover rate has improved since July 2025, with significant customer traffic during holiday periods, confirming the brand's market strength [4][66] 4. Dividend Policy - Haidilao has significantly increased its dividend payout ratio, with plans for a 95% payout in 2024 and maintaining this level in the first half of 2025, resulting in a dividend yield of 5.4% [4][67]

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of HKD 104.10 [1][9][15] Core Views - The report expresses optimism regarding the company's AI driving capabilities and its evolution, highlighting multiple growth avenues including "dual energy + AI + robotics + external cooperation" [5][7] - The company experienced a significant drop in February sales, down 50% year-on-year, attributed to the timing of the Spring Festival and changes in tax incentives for new energy vehicles. However, sales are expected to recover in March with new model launches [6][5] - The second-generation VLA model was launched, enhancing driving capabilities and efficiency, and is expected to support L4 level autonomous driving [7] - The new X9 electric version was introduced, featuring advanced technology and competitive pricing, which is anticipated to boost sales significantly [8] Financial Projections and Valuation - Revenue projections for 2024 are estimated at RMB 40.87 billion, with significant growth expected in subsequent years, reaching RMB 130.50 billion by 2027 [4] - The company is projected to achieve a net profit of RMB 2.41 billion in 2026, with a substantial increase to RMB 5.34 billion by 2027 [4] - The report maintains a price-to-sales (PS) ratio of 0.95x for the automotive sales business, reflecting a premium over comparable companies [9][12] - The overall valuation is estimated at approximately HKD 1,990 million, leading to the target price of HKD 104.10 [15][12]

Investment Rating - The report assigns a "Buy" rating for RiboBio-B (06938) as a first-time coverage [1][7]. Core Insights - RiboBio focuses on the development and industrialization of small nucleic acid drugs, being one of the pioneers in this field. The company has established a fully integrated research and development platform for small nucleic acid drugs, covering various chronic diseases such as cardiovascular, metabolic, kidney, and liver diseases [5][17]. - The small nucleic acid drug industry is entering a period of explosive growth, with a projected compound annual growth rate (CAGR) of 29.4% from 2024 to 2029, driven by advancements in delivery technology and the expansion of indications from rare diseases to chronic diseases [27][28]. - RiboBio's differentiated pipeline includes RBD4059, which targets FXI for thrombotic diseases, RBD5044 for dyslipidemia, and RBD1016 for hepatitis B functional cure, showcasing the company's potential to meet unmet clinical needs [32][46]. Financial Data and Profit Forecast - The company is expected to generate revenues of RMB 143 million in 2024, with a projected growth to RMB 350 million in 2026 and 2027. The net profit attributable to ordinary shareholders is forecasted to be -RMB 270 million in 2024, improving to -RMB 133 million in 2026 [6][8]. - The target price for RiboBio is set at RMB 76.24, equivalent to HKD 86.08, indicating a potential upside of 46% from the market capitalization as of March 4, 2026 [7][8]. Pipeline and Market Opportunities - RiboBio has a robust pipeline with over 20 preclinical drugs and 7 clinical drugs, including 4 in Phase II trials. The core pipeline targets chronic diseases, addressing significant unmet clinical needs [30][31]. - RBD4059 is positioned as the world's first clinical-stage siRNA drug for thrombotic diseases, with a significant market potential as the global anti-thrombotic market is expected to reach USD 59.3 billion by 2024 [32][33]. - RBD5044 aims to address the unmet needs in the dyslipidemia market, which is projected to grow from USD 24 billion in 2019 to USD 35.3 billion by 2029 [46][49]. Key Assumptions and Catalysts - The revenue for 2025-2027 is primarily expected to come from business development (BD) licensing income, with significant milestone payments anticipated from collaborations with partners like Boehringer Ingelheim and Qilu Pharmaceutical [8][9]. - Key clinical data releases for RBD4059, RBD5044, and RBD1016, as well as new licensing agreements with overseas companies, are expected to act as catalysts for stock price performance [10].

Investment Rating - The investment rating for the company is "Outperform the Market" [5] Core Views - The company demonstrated resilient growth in Q4 2025, with revenue reaching 15.4 billion CNY, a year-on-year increase of 20.8%, surpassing Bloomberg's consensus estimate of 16.7% [1][9] - The company's Non-GAAP net profit for Q4 was 3.48 billion CNY, reflecting a 14.7% increase, also exceeding expectations [1][9] - The overall performance in Q4 was strong, with the overseas Trip.com platform maintaining high growth rates during peak season, indicating effective market share acquisition [1][9] - The company is focusing on optimizing user experience and enhancing revenue from transportation services, while domestic hotel prices have stabilized [2][10] - Regulatory developments regarding antitrust investigations and the impact of AI technology on the OTA business model are key areas of focus [3][11] Revenue Breakdown - In Q4 2025, accommodation booking revenue was 6.29 billion CNY (+21.4%), transportation ticketing revenue was 5.37 billion CNY (+12.3%), and vacation revenue was 1.06 billion CNY (+21.4%) [2][10] - Domestic revenue is estimated to have grown at a high single-digit rate, with hotel night growth between 10-15% [2][10] - The Trip.com platform saw a 60% increase in hotel and flight bookings, contributing to a rise in sales expense ratio to 28.1% [2][10] Financial Forecasts - For 2025, the company expects total revenue of 62.4 billion CNY (+17.1%) and Non-GAAP net profit of 31.84 billion CNY, which includes non-recurring investment gains of 19.9 billion CNY from the sale of Makemytrip shares [1][9] - The forecast for Non-GAAP net profit for 2026 and 2027 has been adjusted to 20 billion CNY and 23 billion CNY, respectively, reflecting a cautious outlook due to regulatory concerns and AI impacts [4][12] - The company maintains a robust buyback program with a total of 5 billion USD, which supports shareholder returns [3][11]

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of HKD 144.30 [1]. Core Insights - The company achieved a revenue of USD 15.26 billion in 2025, representing a year-on-year growth of 4.4%, and a net profit attributable to the parent company of USD 1.20 billion, up 6.8% year-on-year. The net profit margin was 7.9%, slightly up by 0.2 percentage points year-on-year. The growth in profit outpaced revenue growth due to an increase in the proportion of high-end products and improved operational efficiency [5][9]. - The company's flagship brands, Milwaukee and RYOBI, demonstrated robust performance, contributing to stable revenue and profit growth. The company is recognized as a global leader in electric tools and outdoor power equipment (OPE), with significant brand and technological advantages [5][6]. - The company is expected to benefit from a recovery in demand for electric and garden tools in North America, driven by customer restocking and a declining interest rate cycle [5][9]. Financial Performance - In 2025, the electric tools segment generated revenue of USD 14.448 billion, a year-on-year increase of 5.3%. The revenue growth was 7.9% in the first half and 2.7% in the second half, with the slowdown in H2 attributed to tariff impacts [6]. - The company’s gross margin improved by 0.9 percentage points to 41.2% in 2025, primarily due to the higher profit contribution from Milwaukee and improved global manufacturing efficiency [8]. - The total operating expenses for 2025 were USD 4.967 billion, up 7.0% year-on-year, with a corresponding expense ratio of 32.5%, an increase of 0.8 percentage points [8]. Revenue and Profit Forecast - Revenue forecasts for 2026 to 2028 are projected at USD 16.552 billion, USD 18.060 billion, and USD 19.637 billion, respectively, with year-on-year growth rates of 8.47%, 9.11%, and 8.73% [4][9]. - The net profit attributable to the parent company is expected to reach USD 1.414 billion in 2026, USD 1.628 billion in 2027, and USD 1.859 billion in 2028, with corresponding growth rates of 18.04%, 15.09%, and 14.21% [4][9]. Valuation Metrics - The company is valued at a PE ratio of 23.91 for 2025, decreasing to 20.26 in 2026, and further to 17.60 in 2027, indicating a positive trend in valuation as earnings grow [4][9]. - The target price of HKD 144.30 is based on a 24x PE for 2026, reflecting the company's strong brand and technological advantages, as well as its resilient growth over the years [9].

Investment Rating - The report maintains a "Hold" rating for the company and raises the target price to HKD 12.50 per share, indicating a potential upside of 14% from the current price of HKD 10.95 [7][13]. Core Insights - The company reported a total revenue of HKD 20.83 billion for 2025, a decrease of 6.7% year-on-year, with a net profit attributable to shareholders of HKD 2.73 billion, down 19% year-on-year. The decline was primarily due to falling prices of float glass, reduced sales of architectural glass, and impairment of financial assets related to polysilicon. Excluding impairment factors, the performance showed strong resilience, exceeding market expectations [3][9]. - The automotive glass segment performed well, generating revenue of HKD 6.86 billion in 2025, an increase of 8.8% year-on-year, with a gross margin improvement of 1.8 percentage points to 54.1%. This growth was driven by increased orders from domestic automakers, proactive marketing in the aftermarket, and a decrease in raw material costs [4][10]. - The float glass segment experienced a revenue decline of 10.8% year-on-year to HKD 11.51 billion, with a gross margin of 18%. Despite a 20% drop in industry average prices, the company maintained a higher profitability due to an increase in the proportion of differentiated products, cost reduction, and overseas expansion [5][11]. - The company's cash and financial position improved significantly, with cash and bank balances reaching HKD 2.92 billion at the end of 2025, a year-on-year increase of 70.7%. The net debt ratio was 5.1%, down 11.2 percentage points, primarily due to operating cash flow used to repay loans and a significant reduction in capital expenditures [6][12]. Financial Summary - For the fiscal year 2025, the company reported total revenue of HKD 20.83 billion, with a projected revenue increase to HKD 21.86 billion in 2026, reflecting a growth rate of 5.0% [8]. - The net profit attributable to shareholders is expected to recover to HKD 3.45 billion in 2026, representing a growth of 26.3% compared to 2025 [8]. - The basic earnings per share are projected to be HKD 0.779 in 2026, with a price-to-earnings ratio of 12.4 times based on the current share price [8].

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of HKD 144.30 [1] Core Views - The company's main business in electric tools shows steady growth, driving profit improvement. Despite a slight miss in net profit expectations due to tariff impacts, the overall revenue and profit growth remain robust, supported by strong performance from flagship brands Milwaukee and RYOBI [5][6] - The company is recognized as a global leader in electric tools and outdoor power equipment (OPE), with significant brand and technological advantages, as well as a strong global production layout and resource allocation capabilities [5][7] - The outlook for 2026 suggests a recovery in demand for electric and garden tools, benefiting from customer restocking and a declining interest rate cycle in North America [5][6] Financial Performance - In 2025, the company achieved revenue of USD 15.26 billion, a year-on-year increase of 4.4%, and a net profit attributable to the parent company of USD 1.20 billion, up 6.8%, resulting in a net profit margin of 7.9% [5][6] - The electric tools segment generated revenue of USD 14.448 billion in 2025, reflecting a year-on-year growth of 5.3%, with Milwaukee and RYOBI brands showing strong performance [6][7] - The company’s gross margin improved to 41.2%, up 0.9 percentage points year-on-year, driven by a higher proportion of high-margin products and improved operational efficiency [8] Earnings Forecast and Valuation - The earnings forecast for 2026-2028 anticipates net profits of USD 1.414 billion, USD 1.628 billion, and USD 1.859 billion respectively, with corresponding EPS of USD 0.77, USD 0.89, and USD 1.02 [9] - The target price is set at HKD 144.30 based on a 24x PE ratio for 2026, reflecting the company's strong brand and technological advantages, as well as its resilient growth over the years [9]

Investment Rating - The report maintains a "Hold" rating for the company and raises the target price to HKD 12.50 per share, indicating a potential upside of 14% from the current price of HKD 10.95 [7][13]. Core Insights - The company reported a total revenue of HKD 20.83 billion for 2025, a decrease of 6.7% year-on-year, with a net profit attributable to shareholders of HKD 2.73 billion, down 19% year-on-year. The decline was primarily due to falling prices of float glass, reduced sales of architectural glass, and impairment of financial assets related to polysilicon. Excluding impairment factors, the performance showed strong resilience, exceeding market expectations [3][9]. - The automotive glass segment performed well, generating revenue of HKD 6.86 billion in 2025, an increase of 8.8% year-on-year, with a gross margin improvement of 1.8 percentage points to 54.1%. This growth was driven by increased orders from domestic automakers and effective marketing in the aftermarket, alongside a decrease in raw material costs [4][10]. - The float glass segment experienced a revenue decline of 10.8% year-on-year to HKD 11.51 billion, with a gross margin of 18%. Despite a 20% drop in industry average prices, the company maintained a higher profitability due to an increase in the proportion of differentiated products, cost reduction, and overseas expansion [5][11]. - The company's cash and financial position improved significantly, with cash and bank balances reaching HKD 2.92 billion at the end of 2025, a year-on-year increase of 70.7%. The net debt ratio decreased to 5.1%, down 11.2 percentage points, primarily due to operating cash flow used to repay loans and a significant reduction in capital expenditures [6][12]. Financial Summary - For the fiscal year 2025, the company reported total revenue of HKD 20.83 billion, with a projected revenue increase to HKD 21.86 billion in 2026, reflecting a growth rate of 5.0% [8]. - The net profit attributable to shareholders is expected to recover to HKD 3.45 billion in 2026, representing a growth of 26.3% compared to 2025 [8]. - The basic earnings per share are projected to be HKD 0.779 in 2026, with a price-to-earnings ratio of 12.4 times based on the current share price [8].

Investment Rating - The investment rating for the company is "Outperform the Market" [5] Core Views - The company demonstrated resilient growth in Q4 2025, with revenue reaching 15.4 billion CNY, a year-on-year increase of 20.8%, surpassing Bloomberg's consensus estimate of 16.7% [1][9] - Non-GAAP net profit for Q4 was 3.48 billion CNY, reflecting a 14.7% increase, also exceeding expectations [1][9] - The company is focusing on optimizing user experience and expanding its market share, particularly in the overseas Trip.com platform, which continues to show strong growth [2][10] - Regulatory developments regarding antitrust investigations and the impact of AI technology on the OTA business model are key areas of focus [3][11] Revenue Breakdown - In Q4 2025, accommodation booking revenue was 6.29 billion CNY (+21.4%), transportation ticketing revenue was 5.37 billion CNY (+12.3%), and vacation revenue was 1.06 billion CNY (+21.4%) [2][10] - Domestic hotel prices have stabilized, and the company is actively targeting both older and younger demographics to enhance its market share [2][10] - The Trip.com platform saw a 60% increase in hotel and flight bookings, contributing to a rise in sales expense ratio to 28.1% [2][10] Financial Forecasts - For 2026 and 2027, the company has adjusted its Non-GAAP net profit forecasts to 20 billion CNY and 23 billion CNY, respectively, with a new estimate for 2028 at 26.5 billion CNY [4][12] - The projected revenue growth rates for the upcoming years are 19.7% for 2024, 17.1% for 2025, and 14.1% for 2026 [5][13] - The company maintains a robust cash position, with cash and cash equivalents expected to reach 46.45 billion CNY in 2025 [13]

Investment Rating - The investment rating for the company is "Buy" and is maintained [4]. Core Insights - In February 2026, the company delivered a total of 15,256 vehicles, representing a year-on-year decrease of 49.9% and a month-on-month decrease of 23.8%. The decline in sales is attributed to the impact of the Spring Festival holiday and seasonal factors. However, with the upcoming launch of the second-generation VLA and a recovery in the automotive market, sales are expected to rebound [2][6]. - The company is entering a new vehicle cycle with the launch of models such as MONA M03 and P7+. The combination of scale enhancement, cost reduction from platforms and technology, and the expansion of software profitability models, along with continued growth in overseas markets, suggests significant future earnings flexibility for the company [2][6]. Summary by Relevant Sections Sales Performance - February 2026 saw the delivery of 15,256 new vehicles, down 49.9% year-on-year and 23.8% month-on-month. Cumulatively, 35,000 vehicles were delivered in January and February 2026, reflecting a year-on-year decrease of 42.0% [2][6]. New Product Launches - The second-generation VLA is set to be launched in March 2026, which is expected to enhance sales as the market recovers. The new models, including the P7+ and the upcoming X9 electric version, are anticipated to drive sales growth [6]. Future Outlook - The company forecasts a delivery volume of 125,000 to 132,000 vehicles for 2025, representing a year-on-year growth of 36.6% to 44.3%. Expected revenue for the same period is projected to be between 21.5 billion to 23 billion yuan, indicating a year-on-year increase of 33.5% to 42.8% [6]. - The company is positioned for a significant year in 2026 with multiple new vehicle launches, which are expected to enhance the sales cycle. The advancements in AI technology and the introduction of new AI applications are likely to lead to a revaluation of the company's stock [6].